Document is current
Any future updates will be listed below
-
Authors
Khwarg, Juyoung
Lee, Heeyong
Yu, Kyung-Sang
Seol, Eunyoung
Chung, Jae-Yong https://orcid.org/0000-0003-4188-2786
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05525780 at ClinicalTrials.govDocuments that mention this clinical trial
Population Pharmacokinetic Modeling and Simulation for Dose Optimization of GB-5001, a Long-Acting Intramuscular Injection of Donepezil, in Healthy Participants
https://doi.org/10.1007/s40120-024-00643-4
-
Funding
Funding for this research was provided by:
G2GBIO
- License Information
-
More Information
Article History
Received: 21 May 2024
Accepted: 1 July 2024
First Online: 10 August 2024
Declarations
:
: Eunyoung Seol and Heeyong Lee are employees of G2GBIO, Inc. Juyoung Khwarg received a scholarship from the BK21FOUR education program. Kyung-sang Yu and Jae-Yong Chung do not have any conflict of interest for this study.
: This clinical study received approval from the institutional review board at Advarra, an independent review committee based in Columbia, MD, USA. This study was registered in the clinical trials registry (NCT05525780), and conducted in compliance with International Council for Harmonisation Good Clinical Practice and the Declaration of Helsinki. Written informed consent was obtained from all participants.
